
Okabion-GB Tablet
Marketer
Instant Remedies Pvt Ltd
Salt Composition
Gabapentin (300mg) + Methylcobalamin (500mcg)
Overview Okabion-GB Tablet
Neuropathic pain is treated with Okabion-GB tablets, a combination medication. Its mechanism involves modulating nerve cell calcium channel activity to reduce pain. Administered orally, Okabion-GB may be taken with or without food, ideally before sleep. Maintaining a regular dosing schedule ensures consistent blood levels. Always follow your doctor's prescribed dosage and duration; if a dose is missed, take it immediately upon recollection. Complete the entire course, even with symptom improvement. Abrupt cessation should only occur under medical supervision. Common adverse effects include nausea, peripheral swelling, ataxia, blurred vision, fever, and nystagmus. Dizziness and drowsiness are also possible; avoid activities requiring alertness until the medication's impact is known. Report any unusual mood shifts, new or worsening depression, or suicidal ideation to your physician. Disclose pregnancy, pregnancy plans, or breastfeeding before commencing treatment. Although generally compatible with other medications, interactions with certain drugs (including antacids and alcohol) can alter its efficacy and heighten adverse reactions.
Primary Ingredients of Okabion-GB Tablet
No text was provided to rewrite.
Uses of Okabion-GB Tablet
Managing neuropathic pain
Major Benefits of Okabion-GB Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not crush, chew, or divide it. Okabion-GB Tablets can be taken with or without food, although consistent timing is recommended.
Common Side effects of Okabion-GB Tablet:
- Dizziness
- Sleepiness
- Tiredness
- Uncoordinated body movements
How to use Okabion-GB Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Okabion-GB Tablets can be consumed with or without food, however, consistent timing is recommended.
How Okabion-GB Tablet works:
Okabion-GB tablets contain Gabapentin and Methylcobalamin, working synergistically to alleviate neuropathic pain. Gabapentin, an alpha-2-delta ligand, reduces pain signals by regulating calcium influx in nerve cells. Methylcobalamin, a B vitamin, supports myelin production, protecting nerve fibers and promoting nerve cell repair. This combined action offers effective relief from nerve damage-related pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Okabion-GB tablets and alcohol may lead to significant somnolence.
PregnancyCONSULT YOUR DOCTOR
The use of Okabion-GB Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Use of Okabion-GB tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant. However, infant monitoring for drowsiness and increased weight is recommended.
DrivingUNSAFE
Taking Okabion-GB Tablets might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Okabion-GB Tablets. Dosage modification may be necessary. A physician's advice is recommended.
LiverCONSULT YOUR DOCTOR
Data regarding Okabion-GB Tablet use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Okabion-GB Tablet :
Should you forget to take your Okabion-GB Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Okabion-GB Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience (Central Nervous System) |
